Kunming Biomed International (KBI) is a world leading contract research organization (CRO) providing preclinical research services. KBI specializes in nonhuman primates (NHP) pharmacological studies and has state-of-the-art AAALAC accredited vivarium, animal research facilities and clinical laboratories. combined with experienced research and scientific teams, high-end clinical , Its purpose-bred NHPs technology platforms and cross-species biomarker programs support a wide-range of services while ensuring consistent high-quality results and rapid turnaround time. KBI provides PK/PD, pathology and exploratory toxicology services. It provides cost effective studies of the highest quality while upholding the highest ethical standards of animal care and welfare.